Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

48/99

BSE: 506197 | NSE: BLISSGVS

Watchlist

NSE BSE

110.75

18-Apr-2024

Open
High
Low
Previous Close

112.25
114.10
108.90
112.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

282005
315.72
149.60
70.85

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,160.50
13.20
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,084.74
0.45%
1.21

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.11
-3.51
9.20

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.12
-5.74
1.93

PAT CAGR (%)

10 Years
5 Years
3 Years

5.62
-10.55
1.14

P:E (Median)

8 Years
5 Years
3 Years

17.95
14.94
15.68

P:BV (Average)

8 Years
5 Years
3 Years

2.13
1.47
1.13

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.82
7.59
6.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 161.33 168.79 -4.42% 171.31 138.85 23.38% 108.99 147.28 -26.00% 143.42 138.30 3.70%
Expenses 132.68 135.33 -1.96% 129.01 112.21 14.97% 97.94 128.13 -23.56% 132.51 119.62 10.78%
EBITDA 28.66 33.46 -14.35% 42.31 26.63 58.88% 11.05 19.15 -42.30% 10.91 18.68 -41.60%
EBIDTM 17.76% 19.82% 24.70% 19.18% 10.14% 13.00% 7.61% 13.51%
Other Income 7.90 11.42 -30.82% 10.61 14.23 -25.44% 6.53 18.63 -64.95% 6.48 12.44 -47.91%
Interest 1.79 1.20 49.17% 1.18 1.84 -35.87% 1.31 2.04 -35.78% 4.97 1.54 222.73%
Depreciation 6.25 3.79 64.91% 5.68 3.74 51.87% 5.36 3.67 46.05% 3.97 3.41 16.42%
PBT 28.52 39.89 -28.50% 46.07 35.29 30.55% 10.90 32.06 -66.00% 8.44 26.17 -67.75%
Tax 7.80 10.61 -26.48% 12.18 9.85 23.65% 3.41 7.42 -54.04% 2.34 7.07 -66.90%
PAT 20.72 29.28 -29.23% 33.89 25.45 33.16% 7.50 24.64 -69.56% 6.11 19.10 -68.01%
PATM 12.84% 17.35% 19.78% 18.33% 6.88% 16.73% 4.26% 13.81%
EPS 1.98 2.80 -29.29% 3.24 2.43 33.33% 0.72 2.35 -69.36% 0.58 1.82 -68.13%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 200.72 205.72 -2.43% 211.88 172.43 22.88% 159.52 188.66 -15.45% 184.78 167.06 10.61%
Expenses 157.03 158.03 -0.63% 157.51 147.88 6.51% 135.31 149.81 -9.68% 178.54 146.90 21.54%
EBITDA 43.69 47.69 -8.39% 54.37 24.55 121.47% 24.21 38.85 -37.68% 6.24 20.17 -69.06%
EBIDTM 21.77% 23.18% 25.66% 14.23% 15.18% 20.59% 3.38% 12.07%
Other Income 5.42 5.65 -4.07% 12.60 2.15 486.05% 5.11 7.01 -27.10% 2.98 12.19 -75.55%
Interest 2.12 1.26 68.25% 1.45 1.91 -24.08% 1.49 2.11 -29.38% 5.08 1.63 211.66%
Depreciation 6.95 4.64 49.78% 6.39 4.60 38.91% 6.19 4.55 36.04% 4.88 4.27 14.29%
PBT 40.04 47.43 -15.58% 59.13 20.19 192.87% 21.65 39.20 -44.77% -0.75 26.45 -
Tax 10.97 17.64 -37.81% 16.09 4.19 284.01% 7.27 11.72 -37.97% -4.22 2.99 -
PAT 29.07 29.79 -2.42% 43.04 16.00 169.00% 14.38 27.48 -47.67% 3.47 23.47 -85.22%
PATM 14.48% 14.48% 20.32% 9.28% 9.01% 14.56% 1.88% 14.05%
EPS 2.64 2.68 -1.49% 4.05 1.33 204.51% 1.41 2.48 -43.15% 0.32 1.89 -83.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 585.05 598.34 636.36 465.51 441.95 426.59 297.89 348.02 326.38 313.02 288.23 Net Sales Growth -1.38% -5.97% 36.70% 5.33% 3.60% 43.20% -14.40% 6.63% 4.27% 8.60% Cost Of Goods Sold 299.05 314.90 343.94 253.30 236.73 225.15 145.81 167.21 114.36 116.45 127.84 Gross Profit 286.00 283.44 292.41 212.21 205.23 201.44 152.08 180.80 212.03 196.57 160.40 GP Margin 48.88% 47.37% 45.95% 45.59% 46.44% 47.22% 51.05% 51.95% 64.96% 62.80% 55.65% Total Expenditure 492.14 508.18 527.16 374.05 341.78 333.49 209.43 247.49 229.87 226.83 222.16 Power & Fuel Cost - 5.80 7.09 6.99 4.70 3.57 2.59 2.73 2.82 2.69 1.80 % Of Sales - 0.97% 1.11% 1.50% 1.06% 0.84% 0.87% 0.78% 0.86% 0.86% 0.62% Employee Cost - 72.54 65.06 58.61 44.02 33.85 26.29 25.03 21.89 17.36 12.93 % Of Sales - 12.12% 10.22% 12.59% 9.96% 7.94% 8.83% 7.19% 6.71% 5.55% 4.49% Manufacturing Exp. - 11.09 10.91 7.13 5.97 4.24 3.64 3.31 23.87 27.77 20.26 % Of Sales - 1.85% 1.71% 1.53% 1.35% 0.99% 1.22% 0.95% 7.31% 8.87% 7.03% General & Admin Exp. - 10.88 12.00 8.70 10.33 13.71 11.11 11.73 17.31 18.20 10.21 % Of Sales - 1.82% 1.89% 1.87% 2.34% 3.21% 3.73% 3.37% 5.30% 5.81% 3.54% Selling & Distn. Exp. - 56.50 55.70 28.56 26.16 31.07 14.77 26.29 35.26 31.20 33.56 % Of Sales - 9.44% 8.75% 6.14% 5.92% 7.28% 4.96% 7.55% 10.80% 9.97% 11.64% Miscellaneous Exp. - 36.48 32.45 10.76 13.88 21.91 5.22 11.18 14.35 13.16 33.56 % Of Sales - 6.10% 5.10% 2.31% 3.14% 5.14% 1.75% 3.21% 4.40% 4.20% 5.40% EBITDA 92.93 90.16 109.20 91.46 100.17 93.10 88.46 100.53 96.51 86.19 66.07 EBITDA Margin 15.88% 15.07% 17.16% 19.65% 22.67% 21.82% 29.70% 28.89% 29.57% 27.53% 22.92% Other Income 31.52 50.77 32.63 19.41 37.00 35.81 10.99 9.08 23.08 21.35 30.12 Interest 9.25 10.06 4.32 5.92 6.62 3.15 6.95 9.07 13.53 11.21 9.44 Depreciation 21.26 15.17 13.85 13.76 8.83 5.75 5.67 5.62 5.85 5.08 4.46 PBT 93.93 115.69 123.66 91.19 121.71 120.01 86.84 94.91 100.21 91.25 82.30 Tax 25.73 30.21 33.74 23.69 29.38 45.58 29.82 35.77 34.60 31.24 28.37 Tax Rate 27.39% 26.11% 26.69% 25.98% 24.14% 37.98% 34.34% 37.69% 34.53% 34.24% 34.47% PAT 68.22 85.48 92.66 67.50 92.33 74.43 57.01 59.13 65.61 60.02 53.93 PAT before Minority Interest 68.22 85.48 92.66 67.50 92.33 74.43 57.01 59.13 65.61 60.02 53.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.66% 14.29% 14.56% 14.50% 20.89% 17.45% 19.14% 16.99% 20.10% 19.17% 18.71% PAT Growth -30.72% -7.75% 37.27% -26.89% 24.05% 30.56% -3.59% -9.88% 9.31% 11.29% EPS 6.52 8.16 8.85 6.45 8.82 7.11 5.45 5.65 6.27 5.73 5.15

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 756.90 751.59 747.45 577.21 689.31 898.57 814.64 798.44 546.89 407.13 344.64 Net Sales Growth 3.14% 0.55% 29.49% -16.26% -23.29% 10.30% 2.03% 46.00% 34.33% 18.13% Cost Of Goods Sold 395.64 401.32 390.98 329.71 439.97 612.26 391.13 358.93 237.18 152.77 132.01 Gross Profit 361.26 350.26 356.47 247.49 249.34 286.31 423.52 439.51 309.72 254.37 212.63 GP Margin 47.73% 46.60% 47.69% 42.88% 36.17% 31.86% 51.99% 55.05% 56.63% 62.48% 61.70% Total Expenditure 628.39 634.26 629.11 470.56 565.99 740.93 617.50 595.70 391.17 303.70 273.42 Power & Fuel Cost - 7.13 8.25 8.14 5.88 4.76 5.49 5.58 4.72 4.36 2.93 % Of Sales - 0.95% 1.10% 1.41% 0.85% 0.53% 0.67% 0.70% 0.86% 1.07% 0.85% Employee Cost - 86.17 76.15 68.09 53.69 42.32 69.23 61.35 33.74 29.43 23.46 % Of Sales - 11.47% 10.19% 11.80% 7.79% 4.71% 8.50% 7.68% 6.17% 7.23% 6.81% Manufacturing Exp. - 12.24 12.09 7.83 7.07 4.95 4.88 5.39 25.65 29.98 41.44 % Of Sales - 1.63% 1.62% 1.36% 1.03% 0.55% 0.60% 0.68% 4.69% 7.36% 12.02% General & Admin Exp. - 16.50 15.03 12.03 13.27 17.05 39.48 36.36 24.68 17.07 15.16 % Of Sales - 2.20% 2.01% 2.08% 1.93% 1.90% 4.85% 4.55% 4.51% 4.19% 4.40% Selling & Distn. Exp. - 63.95 67.18 31.35 28.83 34.72 62.09 92.46 42.51 47.05 35.12 % Of Sales - 8.51% 8.99% 5.43% 4.18% 3.86% 7.62% 11.58% 7.77% 11.56% 10.19% Miscellaneous Exp. - 46.96 59.43 13.40 17.28 24.86 45.21 35.63 22.71 23.03 35.12 % Of Sales - 6.25% 7.95% 2.32% 2.51% 2.77% 5.55% 4.46% 4.15% 5.66% 6.76% EBITDA 128.51 117.33 118.34 106.65 123.32 157.64 197.14 202.74 155.72 103.43 71.22 EBITDA Margin 16.98% 15.61% 15.83% 18.48% 17.89% 17.54% 24.20% 25.39% 28.47% 25.40% 20.67% Other Income 26.11 17.79 31.49 21.95 39.19 37.63 26.54 12.51 24.35 20.29 28.00 Interest 10.14 10.36 4.74 7.24 7.57 4.41 22.80 19.69 18.61 16.41 17.98 Depreciation 24.41 18.67 17.33 17.23 12.59 8.94 21.38 20.14 13.26 11.30 10.68 PBT 120.07 106.07 127.76 104.13 142.35 181.92 179.49 175.40 148.19 96.02 70.56 Tax 30.11 29.34 31.04 30.16 33.71 55.25 56.63 62.72 48.05 34.63 29.53 Tax Rate 25.08% 27.66% 57.30% 28.96% 26.14% 30.37% 38.98% 35.76% 32.42% 36.07% 41.85% PAT 89.96 70.85 15.04 68.49 97.26 123.72 58.78 82.04 82.49 59.91 40.99 PAT before Minority Interest 87.95 76.73 23.13 73.97 95.25 126.66 88.66 112.68 100.15 61.39 41.03 Minority Interest -2.01 -5.88 -8.09 -5.48 2.01 -2.94 -29.88 -30.64 -17.66 -1.48 -0.04 PAT Margin 11.89% 9.43% 2.01% 11.87% 14.11% 13.77% 7.22% 10.28% 15.08% 14.72% 11.89% PAT Growth -7.01% 371.08% -78.04% -29.58% -21.39% 110.48% -28.35% -0.55% 37.69% 46.16% EPS 8.59 6.77 1.44 6.54 9.29 11.82 5.61 7.84 7.88 5.72 3.91

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 937.00 851.43 755.65 682.94 603.27 541.42 491.64 432.07 368.19 314.84 Share Capital 10.42 10.37 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 917.69 831.12 735.50 672.63 592.96 531.11 481.33 421.76 357.87 304.53 Non-Current Liabilities 49.34 35.71 43.87 46.66 40.60 15.73 22.84 21.78 38.76 52.44 Secured Loans 40.69 23.22 32.49 35.55 30.53 5.55 12.47 11.84 30.21 45.14 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.61 1.07 2.50 2.44 1.75 1.91 1.81 1.67 1.40 1.10 Current Liabilities 153.36 192.83 146.11 125.50 91.98 136.85 151.82 243.28 148.05 236.68 Trade Payables 75.87 84.21 66.78 55.95 30.87 35.34 63.80 35.06 50.47 58.99 Other Current Liabilities 50.72 62.46 42.36 32.75 23.47 11.81 11.84 29.10 39.13 28.52 Short Term Borrowings 25.02 41.47 35.38 35.94 36.64 82.53 61.50 49.95 28.38 23.14 Short Term Provisions 1.74 4.69 1.59 0.87 1.01 7.18 14.68 129.17 30.08 126.04 Total Liabilities 1,139.70 1,079.97 945.63 855.10 735.85 694.00 666.30 697.13 555.00 603.96 Net Block 324.82 224.31 174.10 178.86 78.32 72.48 75.34 79.09 81.50 53.53 Gross Block 385.02 269.54 210.93 202.33 93.44 83.40 80.85 122.93 119.59 86.50 Accumulated Depreciation 60.21 45.22 36.84 23.47 15.12 10.92 5.51 43.84 38.08 32.97 Non Current Assets 410.04 288.22 268.98 212.46 157.95 117.72 111.50 212.12 202.08 186.24 Capital Work in Progress 2.80 22.15 2.39 0.00 42.91 0.47 1.98 1.98 0.00 4.31 Non Current Investment 18.26 18.26 18.99 19.00 19.01 19.17 21.54 20.59 19.23 19.23 Long Term Loans & Adv. 17.18 22.44 11.35 13.36 17.38 25.31 12.23 110.45 101.35 109.18 Other Non Current Assets 46.30 0.37 62.15 1.24 0.33 0.29 0.42 0.00 0.00 0.00 Current Assets 729.65 791.74 676.64 642.65 577.90 576.29 554.80 485.02 352.49 416.30 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 74.15 90.11 83.68 60.57 54.84 39.80 28.06 21.95 22.52 21.23 Sundry Debtors 399.06 408.82 348.68 404.91 342.09 282.54 239.41 250.58 210.61 183.53 Cash & Bank 84.61 149.48 119.52 86.62 93.29 70.29 83.57 56.90 47.37 74.12 Other Current Assets 171.83 16.77 23.28 16.30 87.68 183.65 203.76 155.59 71.99 137.41 Short Term Loans & Adv. 157.68 126.55 101.48 74.25 62.40 143.27 173.39 136.36 50.95 124.55 Net Current Assets 576.30 598.91 530.54 517.15 485.92 439.44 402.98 241.74 204.43 179.61 Total Assets 1,139.69 1,079.96 945.62 855.11 735.85 694.01 666.30 697.14 555.00 603.96

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 883.90 818.70 808.25 735.61 646.00 536.24 486.62 412.62 337.08 286.88 Share Capital 10.42 10.37 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 864.59 798.40 788.10 725.30 635.68 525.92 476.31 402.31 326.77 276.57 Non-Current Liabilities 42.84 29.20 45.24 46.32 37.99 12.92 32.81 49.55 67.52 95.65 Secured Loans 40.69 23.22 32.60 37.24 32.54 5.92 25.58 29.62 55.03 78.80 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.62 2.23 8.79 Long Term Provisions 2.69 1.07 2.50 2.44 1.75 1.91 2.05 1.81 1.40 1.10 Current Liabilities 193.26 233.09 203.64 230.53 207.03 299.40 437.09 378.97 242.68 307.66 Trade Payables 86.39 92.61 74.22 89.92 78.88 58.43 98.25 108.49 80.33 82.35 Other Current Liabilities 54.86 67.85 53.69 57.21 50.24 124.46 99.93 52.76 70.30 42.12 Short Term Borrowings 46.01 60.70 65.04 66.39 64.30 105.66 187.47 62.12 61.04 57.05 Short Term Provisions 6.00 11.93 10.69 17.01 13.61 10.85 51.45 155.60 31.00 126.14 Total Liabilities 1,153.53 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 874.24 662.17 700.35 Net Block 378.05 280.76 233.72 240.97 144.97 136.48 303.86 225.25 234.38 213.31 Gross Block 458.74 343.41 285.10 276.07 169.89 157.47 326.83 300.74 293.82 262.45 Accumulated Depreciation 80.69 62.65 51.38 35.10 24.92 20.99 22.97 75.48 59.44 49.14 Non Current Assets 456.15 331.89 311.59 257.48 211.39 170.25 456.97 291.23 244.66 229.67 Capital Work in Progress 2.80 22.15 2.39 0.00 46.74 0.47 4.03 9.10 0.00 4.33 Non Current Investment 2.84 2.39 0.70 0.72 0.72 6.30 1.05 0.11 0.01 0.01 Long Term Loans & Adv. 17.62 24.42 12.63 14.56 18.63 26.72 11.45 56.77 10.27 12.02 Other Non Current Assets 54.16 1.47 62.15 1.24 0.33 0.29 136.58 0.00 0.00 0.00 Current Assets 697.37 776.86 765.20 769.74 693.49 689.79 565.93 583.00 417.08 469.26 Current Investments 4.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 103.06 123.94 98.93 74.14 77.37 59.03 49.30 38.67 33.70 32.53 Sundry Debtors 385.17 392.75 463.82 547.91 460.73 298.48 254.45 300.93 247.47 215.03 Cash & Bank 102.99 177.53 144.55 103.32 106.63 88.86 150.50 78.18 57.29 80.37 Other Current Assets 101.19 14.12 17.55 16.13 48.76 243.41 111.68 165.22 78.62 141.34 Short Term Loans & Adv. 94.56 68.52 40.35 28.24 22.55 146.30 78.44 149.92 60.69 130.30 Net Current Assets 504.11 543.77 561.56 539.21 486.47 390.39 128.84 204.03 174.40 161.60 Total Assets 1,153.52 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 874.23 662.17 700.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 43.81 114.05 66.97 63.22 48.29 22.67 38.48 59.61 15.35 64.71 PBT 115.69 123.66 91.19 121.71 120.01 86.84 94.91 100.21 91.25 82.30 Adjustment 41.42 35.10 41.14 3.43 3.36 0.77 28.12 7.21 14.91 6.89 Changes in Working Capital -75.58 -14.23 -42.64 -30.07 -25.53 -29.06 -47.37 -27.78 -50.62 8.78 Cash after chg. in Working capital 81.53 144.52 89.69 95.08 97.84 58.54 75.65 79.64 55.55 97.97 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.72 -30.47 -22.72 -31.86 -49.55 -35.87 -37.17 -20.03 -40.19 -33.26 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.97 -92.28 -61.62 -60.14 -68.04 16.36 -29.34 -10.29 -21.49 -24.00 Net Fixed Assets -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 -5.32 -28.78 -12.86 Net Investments 0.00 0.73 0.01 0.01 0.16 2.37 -0.95 -1.36 0.00 -0.01 Others 83.16 -14.64 -50.64 5.83 -15.72 15.03 -70.47 -3.61 7.29 -11.13 Cash from Financing Activity -26.05 -12.62 -11.67 -5.83 9.05 -21.91 -14.77 -35.34 -31.23 -49.97 Net Cash Inflow / Outflow 4.79 9.14 -6.33 -2.75 -10.70 17.12 -5.63 13.98 -37.37 -9.26 Opening Cash & Equivalents 13.82 4.67 11.00 13.75 24.45 7.33 12.95 3.40 38.70 52.58 Closing Cash & Equivalent 18.60 13.82 4.67 11.00 13.75 24.45 7.33 12.95 3.40 43.32

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 34.31 135.48 63.97 46.70 39.95 17.64 289.47 112.95 48.94 41.15 PBT 106.07 127.76 104.13 128.97 181.91 179.49 175.40 148.19 96.02 70.56 Adjustment 57.92 -31.71 46.29 26.85 -10.97 17.55 36.24 18.18 22.48 24.11 Changes in Working Capital -85.12 73.37 -57.89 -70.32 -183.07 -140.80 113.48 -8.33 -60.94 -19.30 Cash after chg. in Working capital 78.87 169.42 92.53 85.49 -12.13 56.24 325.13 158.05 57.56 75.36 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -44.56 -33.94 -28.56 -38.79 52.08 -38.61 -35.66 -45.10 -8.63 -34.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.75 -92.98 -46.99 -47.89 -73.52 50.24 -231.25 -49.84 -38.98 -10.90 Net Fixed Assets -96.13 -78.37 -10.99 -65.98 -52.48 -1.04 42.08 -5.32 -28.78 -12.86 Net Investments 0.00 0.73 0.01 0.01 0.16 2.37 -0.95 -1.36 0.00 -0.01 Others 88.38 -15.34 -36.01 18.08 -21.20 48.91 -272.38 -43.16 -10.20 1.97 Cash from Financing Activity -24.94 -23.73 -20.80 -6.30 16.83 -75.98 -10.13 -40.25 -43.26 -8.47 Net Cash Inflow / Outflow 1.62 18.78 -3.82 -7.50 -16.74 -8.10 48.09 22.85 -33.31 21.77 Opening Cash & Equivalents 21.99 13.13 15.34 15.04 36.95 47.41 0.00 5.09 49.57 27.79 Closing Cash & Equivalent 25.01 21.99 13.13 15.34 15.04 36.95 47.41 27.60 16.26 49.57

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 89.11 81.16 72.31 66.21 58.49 52.49 47.66 41.89 35.65 30.39 ROA 7.70% 9.15% 7.50% 11.61% 10.41% 8.38% 8.67% 10.48% 10.36% 10.17% ROE 9.66% 11.68% 9.45% 14.36% 13.00% 11.04% 12.80% 16.41% 17.62% 18.93% ROCE 12.89% 14.68% 12.02% 17.75% 18.80% 15.60% 19.25% 23.43% 23.91% 25.07% Fixed Asset Turnover 1.83 2.65 2.25 2.99 4.82 3.63 3.44 2.70 3.06 3.53 Receivable days 246.41 217.24 295.44 308.46 267.22 319.34 255.29 257.00 228.48 253.33 Inventory Days 50.10 49.84 56.55 47.66 40.49 41.51 26.05 24.78 25.36 28.89 Payable days 92.78 80.11 88.42 48.84 39.16 90.96 75.73 75.81 99.92 138.16 Cash Conversion Cycle 203.74 186.97 263.57 307.29 268.56 269.89 205.62 205.97 153.91 144.06 Total Debt/Equity 0.08 0.10 0.12 0.13 0.12 0.17 0.15 0.19 0.24 0.28 Interest Cover 12.50 30.23 16.40 19.38 39.08 13.49 11.46 8.41 9.14 9.72

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 84.01 78.01 77.41 71.32 62.63 51.99 47.18 40.00 32.64 27.67 ROA 6.78% 2.12% 7.03% 9.86% 14.35% 9.42% 11.88% 13.04% 9.01% 6.46% ROE 9.11% 2.88% 9.64% 13.79% 21.43% 17.34% 25.06% 26.73% 19.74% 15.17% ROCE 12.22% 6.37% 12.49% 17.02% 26.58% 24.61% 31.06% 32.07% 23.57% 20.56% Fixed Asset Turnover 1.87 2.38 2.06 3.09 5.49 3.37 2.56 1.85 1.47 1.48 Receivable days 188.89 209.14 319.89 267.05 154.20 123.80 126.33 182.13 206.07 241.81 Inventory Days 55.12 54.42 54.72 40.11 27.70 24.25 20.01 24.04 29.51 34.22 Payable days 81.40 77.87 90.85 56.62 35.01 51.74 67.63 95.25 108.77 148.76 Cash Conversion Cycle 162.62 185.69 283.75 250.53 146.89 96.31 78.70 110.92 126.81 127.26 Total Debt/Equity 0.11 0.13 0.15 0.16 0.16 0.22 0.46 0.32 0.47 0.60 Interest Cover 11.23 12.42 15.38 18.04 42.21 7.37 9.91 8.96 6.85 4.92

Top Investors:

arian investment limited

life insurance corporation of india

gulbarga trading and investment private

arjun gautam ashra .

gautam rasiklal ashra

investor education and protection fund authority ministry of corporate affairs

aspire emerging fund

polus global fund

Annual Reports:

News Update:

Bliss GVS Pharma - Quarterly Results
23rd Jan 2024, 23:36 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback